Quality indicators for inflammatory bowel disease: development of process and outcome measures.

Timing of hepatic artery reperfusion and biliary strictures in liver transplantation.

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Transcriptional Modulation of the ERK1/2 MAPK and NF-ÎşB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC.

Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?

Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: evaluation of radiological and pathological response.

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.

Identification and characterization of adverse effects in 21st century toxicology.

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.

Liver transplantation for hepatocellular carcinoma: defining the impact of using extended criteria liver allografts.

Transcriptional profile of diuron-induced toxicity on the urinary bladder of male Wistar rats to inform mode of action.

Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximab.

Pathology peer review.

Effects of prenatal exposure to a low dose atrazine metabolite mixture on pubertal timing and prostate development of male Long-Evans rats.